Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental biologics license ...

Last year, Sanofi's ($SNY) fourth-quarter flu vaccine sales soared on the introduction of a quadrivalent contender, surging more than 94%. Now, looking to keep that ...

Sanofi announced that the Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for Fluzone Intradermal Quadrivalent vaccine for active immunization for ...

The Fluzone vaccines should not be given to any individual with a severe allergic reaction to any vaccine component, including eggs, egg products, thimerosol, or to a previous dose of any flu vaccine.

The US Food and Drug Administration (FDA) today approved a 4-strain inactivated influenza virus vaccine from Sanofi Pasteur (Fluzone Quadrivalent) for use in children aged 6 months or older, ...

Please provide your email address to receive an email when new articles are posted on . The FDA today approved an intradermal quadrivalent influenza vaccine containing two influenza A and two ...

Fluzone (influenza) is a prescription vaccine used to prevent or reduce the risks of influenza infection. Fluzone can cause side effects that range from mild to serious, including injection site ...

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/h65mff/fluzone) has announced the addition of GlobalData's new report ...

SWIFTWATER, Pa. and SAN FRANCISCO, Oct. 5, 2012 /PRNewswire/ -- Sanofi Pasteur will bring its Fluzone ® Intradermal Vaccine Coop de Quill VacciNation Tour to San Francisco this Saturday, Oct. 6, as ...

FDA approves Fluzone ® High-Dose Quadrivalent (Influenza Vaccine) for adults 65 years of age and older *Will be available in fall 2020, in time for the 2020-2021 flu season PARIS - November 4, 2019 – ...